The increase in the CRP levels further confirms the increased inflammatory conditions (hypercoagulability and activated platelets) in COVID-19 patients, as CRP is an acute marker of inflammation but, also, plays a role in the acute-phase immune response in the body [41]. This evidence concerns the gene CRP and thrombophilia.